Pharmaceuticals Market Size, Share & Industry Analysis, By Type (Drugs {Prescription & OTC} and Vaccines {Bacterial & Viral}), By Disease Indication (Oncology, Diabetes, Infectious, Cardiovascular, Obesity, Autoimmune, Ophthalmic, Gastrointestinal, Dermatology, Hematology, Hormonal, Allergies), By Drug Type (Biologics & Biosimilars {Antibodies [Monoclonal Antibodies, Antibody-Drug Conjugates], Vaccines, Peptide-Drug Conjugates}, & Conventional Drugs), By Route of Administration, By Distribution Channel (Hospitals, Drug Stores, Retail & Online Pharmacies), & Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI102685

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. New Product Launches, By Key Players
2. Key Industry Developments (Mergers, Acquisitions & Partnerships, etc.)
3. Impact of COVID-19 on the Market
4. Pipeline Analysis, By Key Players
5. Overview: Promising Therapeutics Areas
6. Overview: Investment Trend in Pharma & Biotech
7. Prevalence/Incidence of Key Diseases, By Key Countries
Global Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. China
  2. Japan
  3. India
  4. South Korea
  5. Singapore
  6. Vietnam
  7. Australia
  8. Rest of Asia Pacific
Latin America Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Saudi Arabia
  2. UAE
  3. South Africa
  4. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. Merck & Co., Inc.
  2. Pfizer Inc.
  3. Johnson & Johnson
  4. AbbVie Inc.
  5. AstraZeneca
  6. F. Hoffmann-La Roche Ltd
  7. Novartis AG
  8. Bristol-Myers Squibb Company
  9. Eli Lilly and Company
  10. Sanofi
  11. Novo Nordisk A/S
  12. GSK plc.
  13. Amgen Inc.
  14. Gilead Sciences, Inc.
  15. Takeda Pharmaceutical Company Limited
  16. Other Prominent Players

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. New Product Launches, By Key Players
2. Key Industry Developments (Mergers, Acquisitions & Partnerships, etc.)
3. Impact of COVID-19 on the Market
4. Pipeline Analysis, By Key Players
5. Overview: Promising Therapeutics Areas
6. Overview: Investment Trend in Pharma & Biotech
7. Prevalence/Incidence of Key Diseases, By Key Countries
Global Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. China
  2. Japan
  3. India
  4. South Korea
  5. Singapore
  6. Vietnam
  7. Australia
  8. Rest of Asia Pacific
Latin America Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Prescription
    2. OTC
  2. Vaccines
    1. Bacterial
    2. Viral
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Oncology
  2. Diabetes
  3. Infectious
  4. Cardiovascular
  5. Neurology & Psychiatry
  6. Respiratory
  7. Renal
  8. Obesity
  9. Autoimmune
  10. Ophthalmic
  11. Gastrointestinal
  12. Dermatology
  13. Hematology/Blood
  14. Liver/Hepatology
  15. Genetic
  16. Hormonal/Endocrine
  17. Women’s Health
  18. Reproductive
  19. Allergies
  20. Others
3. Market Analysis, Insights and Forecast – By Drug Type
  1. Biologics & Biosimilars
    1. Antibodies
      1. Monoclonal Antibodies (mAbs)
      2. Bispecific Antibodies
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
    2. Vaccines
    3. Peptides/Peptide-Drug Conjugates (PDCs)
    4. Others
  2. Small Molecules/Conventional Drugs
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Inhalation
  5. Others
5. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Saudi Arabia
  2. UAE
  3. South Africa
  4. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. Merck & Co., Inc.
  2. Pfizer Inc.
  3. Johnson & Johnson
  4. AbbVie Inc.
  5. AstraZeneca
  6. F. Hoffmann-La Roche Ltd
  7. Novartis AG
  8. Bristol-Myers Squibb Company
  9. Eli Lilly and Company
  10. Sanofi
  11. Novo Nordisk A/S
  12. GSK plc.
  13. Amgen Inc.
  14. Gilead Sciences, Inc.
  15. Takeda Pharmaceutical Company Limited
  16. Other Prominent Players

Read Less

List of Figures

Figure 1: Global Pharmaceuticals Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Pharmaceuticals Market Value Share (%), By Type, 2024 & 2032

Figure 3: Global Pharmaceuticals Market Value Share (%), By Disease Indication, 2024 & 2032

Figure 4: Global Pharmaceuticals Market Value Share (%), By Drug Type, 2024 & 2032

Figure 5: Global Pharmaceuticals Market Value Share (%), By Route of Administration, 2024 & 2032

Figure 6: Global Pharmaceuticals Market Value Share (%), By Age Group, 2024 & 2032

Figure 7: Global Pharmaceuticals Market Value Share (%), By Distribution Channel, 2024 & 2032

Figure 8: Global Pharmaceuticals Market Value (USD billion), by Region, 2024 & 2032

Figure 9: North America Pharmaceuticals Market Value (USD billion), By Type, 2024 & 2032

Figure 10: North America Pharmaceuticals Market Value Share (%), By Type, 2024

Figure 11: North America Pharmaceuticals Market Value (USD billion), By Disease Indication, 2024 & 2032

Figure 12: North America Pharmaceuticals Market Value Share (%), By Disease Indication, 2024

Figure 13: North America Pharmaceuticals Market Value (USD billion), By Drug Type, 2024 & 2032

Figure 14: North America Pharmaceuticals Market Value Share (%), By Drug Type, 2024

Figure 15: North America Pharmaceuticals Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 16: North America Pharmaceuticals Market Value Share (%), By Route of Administration, 2024

Figure 17: North America Pharmaceuticals Market Value (USD billion), By Age Group, 2024 & 2032

Figure 18: North America Pharmaceuticals Market Value Share (%), By Age Group, 2024

Figure 19: North America Pharmaceuticals Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 20: North America Pharmaceuticals Market Value Share (%), By Distribution Channel, 2024

Figure 21: North America Pharmaceuticals Market Value (USD billion), By Country, 2024 & 2032

Figure 22: North America Pharmaceuticals Market Value Share (%), By Country, 2024

Figure 23: Europe Pharmaceuticals Market Value (USD billion), By Type, 2024 & 2032

Figure 24: Europe Pharmaceuticals Market Value Share (%), By Type, 2024

Figure 25: Europe Pharmaceuticals Market Value (USD billion), By Disease Indication, 2024 & 2032

Figure 26: Europe Pharmaceuticals Market Value Share (%), By Disease Indication, 2024

Figure 27: Europe Pharmaceuticals Market Value (USD billion), By Drug Type, 2024 & 2032

Figure 28: Europe Pharmaceuticals Market Value Share (%), By Drug Type, 2024

Figure 29: Europe Pharmaceuticals Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 30: Europe Pharmaceuticals Market Value Share (%), By Route of Administration, 2024

Figure 31: Europe Pharmaceuticals Market Value (USD billion), By Age Group, 2024 & 2032

Figure 32: Europe Pharmaceuticals Market Value Share (%), By Age Group, 2024

Figure 33: Europe Pharmaceuticals Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 34: Europe Pharmaceuticals Market Value Share (%), By Distribution Channel, 2024

Figure 35: Europe Pharmaceuticals Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 36: Europe Pharmaceuticals Market Value Share (%), By Country/ Sub-region, 2024

Figure 37: Asia Pacific Pharmaceuticals Market Value (USD billion), By Type, 2024 & 2032

Figure 38: Asia Pacific Pharmaceuticals Market Value Share (%), By Type, 2024

Figure 39: Asia Pacific Pharmaceuticals Market Value (USD billion), By Disease Indication, 2024 & 2032

Figure 40: Asia Pacific Pharmaceuticals Market Value Share (%), By Disease Indication, 2024

Figure 41: Asia Pacific Pharmaceuticals Market Value (USD billion), By Drug Type, 2024 & 2032

Figure 42: Asia Pacific Pharmaceuticals Market Value Share (%), By Drug Type, 2024

Figure 43: Asia Pacific Pharmaceuticals Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 44: Asia Pacific Pharmaceuticals Market Value Share (%), By Route of Administration, 2024

Figure 45: Asia Pacific Pharmaceuticals Market Value (USD billion), By Age Group, 2024 & 2032

Figure 46: Asia Pacific Pharmaceuticals Market Value Share (%), By Age Group, 2024

Figure 47: Asia Pacific Pharmaceuticals Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 48: Asia Pacific Pharmaceuticals Market Value Share (%), By Distribution Channel, 2024

Figure 49: Asia Pacific Pharmaceuticals Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 50: Asia Pacific Pharmaceuticals Market Value Share (%), By Country/ Sub-region, 2024

Figure 51: Latin America Pharmaceuticals Market Value (USD billion), By Type, 2024 & 2032

Figure 52: Latin America Pharmaceuticals Market Value Share (%), By Type, 2024

Figure 53: Latin America Pharmaceuticals Market Value (USD billion), By Disease Indication, 2024 & 2032

Figure 54: Latin America Pharmaceuticals Market Value Share (%), By Disease Indication, 2024

Figure 55: Latin America Pharmaceuticals Market Value (USD billion), By Drug Type, 2024 & 2032

Figure 56: Latin America Pharmaceuticals Market Value Share (%), By Drug Type, 2024

Figure 57: Latin America Pharmaceuticals Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 58: Latin America Pharmaceuticals Market Value Share (%), By Route of Administration, 2024

Figure 59: Latin America Pharmaceuticals Market Value (USD billion), By Age Group, 2024 & 2032

Figure 60: Latin America Pharmaceuticals Market Value Share (%), By Age Group, 2024

Figure 61: Latin America Pharmaceuticals Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 62: Latin America Pharmaceuticals Market Value Share (%), By Distribution Channel, 2024

Figure 63: Latin America Pharmaceuticals Market Value (USD billion), By Country, 2024 & 2032

Figure 64: Latin America Pharmaceuticals Market Value Share (%), By Country/Sub-region, 2024

Figure 65: Middle East & Africa Pharmaceuticals Market Value (USD billion), By Type, 2024 & 2032

Figure 66: Middle East & Africa Pharmaceuticals Market Value Share (%), By Type, 2024

Figure 67: Middle East & Africa Pharmaceuticals Market Value (USD billion), By Disease Indication, 2024 & 2032

Figure 68: Middle East & Africa Pharmaceuticals Market Value Share (%), By Disease Indication, 2024

Figure 69: Middle East & Africa Pharmaceuticals Market Value (USD billion), By Drug Type, 2024 & 2032

Figure 70: Middle East & Africa Pharmaceuticals Market Value Share (%), By Drug Type, 2024

Figure 71: Middle East & Africa Pharmaceuticals Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 72: Middle East & Africa Pharmaceuticals Market Value Share (%), By Route of Administration, 2024

Figure 73: Middle East & Africa Pharmaceuticals Market Value (USD billion), By Age Group, 2024 & 2032

Figure 74: Middle East & Africa Pharmaceuticals Market Value Share (%), By Age Group, 2024

Figure 75: Middle East & Africa Pharmaceuticals Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 76: Middle East & Africa Pharmaceuticals Market Value Share (%), By Distribution Channel, 2024

Figure 77: Middle East & Africa Pharmaceuticals Market Value (USD billion), By Country, 2024 & 2032

Figure 78: Middle East & Africa Pharmaceuticals Market Value Share (%), By Country/Sub-region, 2024

Figure 79: Global Pharmaceuticals Market Share (%), By Company, 2024

List of Tables

Table 1: Global Pharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 2: Global Pharmaceuticals Market Revenue (USD billion) Forecast, By Drugs, 2019–2032

Table 3: Global Pharmaceuticals Market Revenue (USD billion) Forecast, By Vaccines, 2019–2032

Table 4: Global Pharmaceuticals Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 5: Global Pharmaceuticals Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 6: Global Pharmaceuticals Market Revenue (USD billion) Forecast, By Biologics & Biosimilars, 2019–2032

Table 7: Global Pharmaceuticals Market Revenue (USD billion) Forecast, By Antibodies, 2019–2032

Table 8: Global Pharmaceuticals Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 9: Global Pharmaceuticals Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 10: Global Pharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 11: Global Pharmaceuticals Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 12: North America Pharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 13: North America Pharmaceuticals Market Revenue (USD billion) Forecast, By Drugs, 2019–2032

Table 14: North America Pharmaceuticals Market Revenue (USD billion) Forecast, By Vaccines, 2019–2032

Table 15: North America Pharmaceuticals Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 16: North America Pharmaceuticals Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 17: North America Pharmaceuticals Market Revenue (USD billion) Forecast, By Biologics & Biosimilars, 2019–2032

Table 18: North America Pharmaceuticals Market Revenue (USD billion) Forecast, By Antibodies, 2019–2032

Table 19: North America Pharmaceuticals Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 20: North America Pharmaceuticals Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 21: North America Pharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 22: North America Pharmaceuticals Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 23: Europe Pharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 24: Europe Pharmaceuticals Market Revenue (USD billion) Forecast, By Drugs, 2019–2032

Table 25: Europe Pharmaceuticals Market Revenue (USD billion) Forecast, By Vaccines, 2019–2032

Table 26: Europe Pharmaceuticals Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 27: Europe Pharmaceuticals Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 28: Europe Pharmaceuticals Market Revenue (USD billion) Forecast, By Biologics & Biosimilars, 2019–2032

Table 29: Europe Pharmaceuticals Market Revenue (USD billion) Forecast, By Antibodies, 2019–2032

Table 30: Europe Pharmaceuticals Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 31: Europe Pharmaceuticals Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 32: Europe Pharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 33: Europe Pharmaceuticals Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 34: Asia Pacific Pharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 35: Asia Pacific Pharmaceuticals Market Revenue (USD billion) Forecast, By Drugs, 2019–2032

Table 36: Asia Pacific Pharmaceuticals Market Revenue (USD billion) Forecast, By Vaccines, 2019–2032

Table 37: Asia Pacific Pharmaceuticals Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 38: Asia Pacific Pharmaceuticals Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 39: Asia Pacific Pharmaceuticals Market Revenue (USD billion) Forecast, By Biologics & Biosimilars, 2019–2032

Table 40: Asia Pacific Pharmaceuticals Market Revenue (USD billion) Forecast, By Antibodies, 2019–2032

Table 41: Asia Pacific Pharmaceuticals Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 42: Asia Pacific Pharmaceuticals Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 43: Asia Pacific Pharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 44: Asia Pacific Pharmaceuticals Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 45: Latim America Pharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 46: Latim America Pharmaceuticals Market Revenue (USD billion) Forecast, By Drugs, 2019–2032

Table 47: Latim America Pharmaceuticals Market Revenue (USD billion) Forecast, By Vaccines, 2019–2032

Table 48: Latim America Pharmaceuticals Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 49: Latim America Pharmaceuticals Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 50: Latim America Pharmaceuticals Market Revenue (USD billion) Forecast, By Biologics & Biosimilars, 2019–2032

Table 51: Latim America Pharmaceuticals Market Revenue (USD billion) Forecast, By Antibodies, 2019–2032

Table 52: Latim America Pharmaceuticals Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 53: Latim America Pharmaceuticals Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 54: Latim America Pharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 55: Latim America Pharmaceuticals Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 56: Middle East & Africa Pharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 57: Middle East & Africa Pharmaceuticals Market Revenue (USD billion) Forecast, By Drugs, 2019–2032

Table 58: Middle East & Africa Pharmaceuticals Market Revenue (USD billion) Forecast, By Vaccines, 2019–2032

Table 59: Middle East & Africa Pharmaceuticals Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 60: Middle East & Africa Pharmaceuticals Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 61: Middle East & Africa Pharmaceuticals Market Revenue (USD billion) Forecast, By Biologics & Biosimilars, 2019–2032

Table 62: Middle East & Africa Pharmaceuticals Market Revenue (USD billion) Forecast, By Antibodies, 2019–2032

Table 63: Middle East & Africa Pharmaceuticals Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 64: Middle East & Africa Pharmaceuticals Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 65: Middle East & Africa Pharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 66: Middle East & Africa Pharmaceuticals Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Impact of Covid-19 on Pharmaceuticals Market

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 300

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com